Regulatory Landscape
How the FD&C Act, compounding law, and the FDA’s bulks-list process shape research-chemical access — including a real, current case study. Complete all 4 lessons and pass the quiz to earn your Regulatory Landscape certificate.
Progress saves automatically in your browser.
What “Research Use Only” Means Under the FD&C Act
Why that label exists, and the legal framework behind “not evaluated by the FDA” and “not for human or veterinary use.”
7 min
Compounding and the 503A Bulks List
What compounding pharmacies are, and how FDA’s interim bulks-list categories (1, 2, and 3) work.
7 min
A Real Case Study: The 2026 PCAC Peptide Review
What actually happened when FDA’s advisory committee reviewed BPC-157 and six other peptides for the 503A Bulks List.
8 min
Why Regulatory Status Isn’t Permanent
Advisory recommendations vs. binding rulemaking, and why checking current status yourself matters.
6 min